Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Future perspectives: towards interferon-free regimens for HCV.

Antiviral therapy - 1 Jan 2012

Gane Ed

Abstract excerpt

The current epidemic of HCV infection affects almost 180 million people, of whom one quarter already has cirrhosis. The number with hepatocellular carcinoma and liver failure are projected to treble over the next three decades. The only means of reducing this health burden is through increased eradication with antiviral therapy. However, current antiviral therapies are limited by poor efficacy and tolerability,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferons

Share to Oligopeptides

Share to Proline

Share to Ribavirin

Source

Identifiers

PMID: 23186654
DOI: 10.3851/IMP2431

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Future perspectives: towards interferon-free regimens for HCV.PMID 23186654Read ↗

Interferon free therapy with direct acting antivirals for HCV.Semantic proximity Read ↗

Interferon-free regimens for hepatitis C: combine and conquer.Semantic proximity Read ↗

Optimal IFN-free therapy in treatment-naïve patients with HCV genotype 1 infection.Semantic proximity Read ↗

Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review.Semantic proximity Read ↗

Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives.Semantic proximity Read ↗

Optimizing triple therapy and IFN/RBV-free regimens for hepatitis C virus infection.Semantic proximity Read ↗

Interferon-free regimens: the near future, the likely and the not so likely.Semantic proximity Read ↗

Direct-acting antivirals: the endgame for hepatitis C?Semantic proximity Read ↗

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues.Semantic proximity Read ↗

Optimal interferon-free therapy in treatment-experienced chronic hepatitis C patients.Semantic proximity Read ↗

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors.Semantic proximity Read ↗

Treatment of hepatitis C in patients with cirrhosis: remaining challenges for direct-acting antiviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.